Report Overview:
Probiotics for pregnant women are specially formulated microbial supplements containing beneficial strains like Lactobacillus and Bifidobacterium that support maternal and fetal health. These live microorganisms work by modulating gut microbiota composition, enhancing nutrient absorption, and boosting immune function - particularly important during pregnancy when digestive issues and immune system changes are common. Clinical studies suggest specific probiotic strains may help reduce risks of gestational diabetes, preeclampsia, and infant allergies.
The market growth is driven by increasing awareness about prenatal nutrition and rising scientific validation of probiotics' benefits for pregnancy outcomes. However, regulatory variations across regions and product stability challenges present hurdles. North America currently dominates with over 35% market share, while Asia-Pacific shows the fastest growth potential due to expanding middle-class populations and improving healthcare access.
Market Value:
Global pregnant women probiotics market size was valued at USD 728 million in 2024 and is projected to grow from USD 762 million in 2025 to USD 995 million by 2032, exhibiting a CAGR of 4.7% during the forecast period.
4.7% (2024 – 2032)
By Applications:
Gut health maintenance
Immune system support
Nutritional supplement
Postpartum recovery
By Types:
• Probiotic Powder
• Probiotic Drops
• Probiotic Capsules
• Others
Key players include:
• BioGaia AB (Sweden)
• Contrale (Netherlands)
• Nutrition Care (Australia)
• Synbiotics (France)
• Natural Factors (Canada)
• NOVA Probiotics (U.S.)
